Loading...
Loading...
Contributors:
Dataset URI:
6b9b81e0-a47b-492d-88cf-19c2baef648bThe purpose of this study was evaluate the efficacy and safety of alogliptin, once daily (QD) combined with an Sulfonylurea taken QD or twice daily (BID) in type 2 diabetic patients with uncontrolled blood glucose.
Keyword(s):
Alogliptin; Alogliptin and glimepiride; Endocrinology/Metabolism/Bone; Glimepiride; Glycosylated Hemoglobin.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)